Efficacy and safety of topical niacinamide for acne vulgaris Akne vulgaris tedavisinde topikal niasinamid'in etkinliǧi ve güenirliǧi
Turkderm Deri Hastaliklari ve Frengi Arsivi, cilt.45, sa.2, ss.93-96, 2011 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 45 Sayı: 2
- Basım Tarihi: 2011
- Doi Numarası: 10.4274/turkderm.45.21
- Dergi Adı: Turkderm Deri Hastaliklari ve Frengi Arsivi
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.93-96
- Anahtar Kelimeler: Acne vulgaris, niacinamide, quality of life
- Sağlık Bilimleri Üniversitesi Adresli: Hayır
Özet
Background and Design: To investigate the efficacy and safety of topical 4% naicinamide gel cream in the treatment of mild to moderate acne vulgaris and to assess the quality of life of acne patients. Material and Method: Twenty-nine female patients aged 16-38 (mean: 23.57±5.42) years with mild to moderate acne vulgaris who presented in dermatology outpatient clinic were enrolled in the study. All patients applied 4% niacinamide gel cream (Vivatinellacnecinamide gel cream®) on their faces twice daily for eight weeks. The number of lesions (inflammatory and non-inflammatory) was counted at 0, 2, 4 and 8 weeks. The side effects (erythema, desquamation, burning and dryness) were recorded. The Skindex-29, a quality-of-life measure for patients with skin disease, was administered to the subjects at the beginning and the end of treatment. Results: The decrease in the mean number of inflammatory lesions was statistically significant at the end of the treatment (pre-treatment vs. post-treatment: 12.24 vs. 6.14; p =0.000). However, there was no statistically significant decrease in the number of non-inflammatory lesions at the end of the eight weeks. The niacinamide gel cream was generally well tolerated. There was statistically significant improvement in the Skindex-29 scale scores (p =0.000) at the end of the treatment. Conclusion: Topical 4% niacinamide gel cream may be an alternative treatment for inflammatory lesions of mild to moderate acne vulgaris.